Happy new year to all PTX holders and management alike.
Agree mal, crux time 2019/2020 for this spec company to shine.
For the record, Regal funds management held strong for 2 years before the sell down. People sell for many reasons, as you say other majors are holding tight.
Have increased my holdings by approximately 20% with further orders pending.
Back to business though.
If the breastcancer phase 2 results mirror (replication) the 1b results then holding is a no brainer (IMO).
Should c the clinical commencement of the Ptx-100 compound this half of the year.
Second half will be of further interest as the AML and ovarian cancer trial results come through.
Reminder of ‘curve ball theory’, unforeseen events between timeline expectancies May or may not happen.
Interesting to see the Quarter out by end of the month.
Passport ready (sorry, running wish), again wishing all holders safe an best health year ahead.
PTX Price at posting:
6.9¢ Sentiment: Buy Disclosure: Held
